Print  |  Close

Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics


Active: Yes
Cancer Type: Breast Cancer
Colon/Rectal Cancer
Lung Cancer
Lymphoma
Melanoma
Non-Hodgkin Lymphoma
Solid Tumor
Unknown Primary
NCT ID: NCT06418204
Trial Phases: Protocol IDs: WF2304-A172401 (primary)
WF2304-A172401
WF2304-A172401
NCI-2024-03314
Eligibility: 18 Years and older, Male and Female Study Type: Supportive care
Study Sponsor: Wake Forest NCORP Research Base
NCI Full Details: http://clinicaltrials.gov/show/NCT06418204

Summary

This study evaluates complementary approaches (e.g use of substances such as cannabis or dietary supplements, as well as therapies like acupuncture or meditation) that patients use to manage cancer-related symptoms during active treatment for breast cancer, colorectal cancer, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer.

Objectives

PRIMARY OBJECTIVE:
I. To examine the association between cannabis and/or cannabinoid use and cancer-related symptoms assessed monthly for one year in adults newly diagnosed with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer who are planning or recently started to receive one or more systemic cancer directed therapies with chemotherapy and/or immune check point inhibitors (ICIs) targeting PD-1, PD-L1 or CTLA-4.

OUTLINE: This is an observational study.

Patients complete surveys and have their medical records reviewed and may optionally undergo blood sample collection on study.
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.